{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:40:18Z","timestamp":1773877218209,"version":"3.50.1"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004035","name":"Jordan University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019004","name":"Jordan University of Science and Technology Deanship of Research","doi-asserted-by":"publisher","award":["20230010"],"award-info":[{"award-number":["20230010"]}],"id":[{"id":"10.13039\/501100019004","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012973","name":"Universit\u00e9 de Moncton","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.amjms.2025.11.009","type":"journal-article","created":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T07:30:21Z","timestamp":1763969421000},"page":"350-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interrelationships between diabetes and atrial fibrillation: Comparative assessment of clinical markers and possible therapeutic implications"],"prefix":"10.1016","volume":"371","author":[{"given":"Doa\u2019a","family":"Al-u'datt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Mahmoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2026-819X","authenticated-orcid":false,"given":"Carole C.","family":"Tranchant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sukaina","family":"Rawashdeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayssar","family":"Tashtush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kareem S.","family":"Almoghrabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya F.","family":"Alfwaress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2025.11.009_bib0001","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.amjcard.2021.02.014","article-title":"Incidence and mortality trends of atrial fibrillation\/atrial flutter in the United States 1990 to 2017","volume":"148","author":"DeLago","year":"2021","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.11.009_bib0002","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/1747493019897870","article-title":"Global epidemiology of atrial fibrillation: an increasing epidemic and public health challenge","volume":"16","author":"Lippi","year":"2021","journal-title":"Int J Stroke"},{"key":"10.1016\/j.amjms.2025.11.009_bib0003","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.123.012143","article-title":"Mortality, hospitalization, and cardiac interventions in patients with atrial fibrillation aged <65 years","volume":"17","author":"Bhonsale","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0004","first-page":"348","article-title":"Atrial fibrillation and ischemic stroke: a clinical review","volume":"41","author":"Migdady","year":"2021","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/14779072.2023.2160319","article-title":"Atrial fibrillation and stroke","volume":"21","author":"Choi","year":"2023","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"2","key":"10.1016\/j.amjms.2025.11.009_bib0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.15420\/aer.2018.18.2","article-title":"Risk factor management in atrial fibrillation","volume":"7","author":"Brandes","year":"2018","journal-title":"Arrhythm Electrophysiol Rev"},{"issue":"9665","key":"10.1016\/j.amjms.2025.11.009_bib0007","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0140-6736(09)60443-8","article-title":"Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study","volume":"373","author":"Schnabel","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.amjms.2025.11.009_bib0008","doi-asserted-by":"crossref","first-page":"850","DOI":"10.4239\/wjd.v6.i6.850","article-title":"Diabetes mellitus: the epidemic of the century","volume":"6","author":"Kharroubi","year":"2015","journal-title":"World J Diabetes"},{"issue":"10408","key":"10.1016\/j.amjms.2025.11.009_bib0009","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2025.11.009_bib0010","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.amjms.2025.11.009_bib0011","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2025.11.009_bib0012","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.numecd.2010.01.008","article-title":"Cardiovascular risk in women with diabetes","volume":"20","author":"Rivellese","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.amjms.2025.11.009_bib0013","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jacc.2017.07.755","article-title":"Care patterns and outcomes in atrial fibrillation patients with and without diabetes: ORBIT-AF registry","volume":"70","author":"Echouffo-Tcheugui","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0014","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.446","article-title":"Insights into type 2 diabetes mellitus in atrial fibrillation patients: a proteomics approach","volume":"45","author":"Atzemian","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2025.11.009_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118619","article-title":"Age drives the impact of vascular disease on ischemic stroke in patients with atrial fibrillation: role of hypertension and prediabetes","volume":"399","author":"Mone","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.amjms.2025.11.009_bib0017","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1093\/cvr\/cvab017","article-title":"Relationship between lipoproteins, thrombosis, and atrial fibrillation","volume":"118","author":"Ding","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.amjms.2025.11.009_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004067","article-title":"Lipids and atrial fibrillation: new insights into a paradox","volume":"19","author":"Sagris","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/j.amjms.2025.11.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/ehaa946.0451","article-title":"The cholesterol paradox in atrial fibrillation: results from the LIPIDOGRAM 2015 study","volume":"41","author":"Harrison","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjms.2025.11.009_bib0020","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1253\/circj.CJ-11-0780","article-title":"Association between lipid profile and risk of atrial fibrillation","volume":"75","author":"Watanabe","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/j.amjms.2025.11.009_bib0021","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.12659\/MSM.907580","article-title":"Association between blood lipid profiles and atrial fibrillation: a case-control study","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit"},{"issue":"11","key":"10.1016\/j.amjms.2025.11.009_bib0022","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0895-7061(03)01015-X","article-title":"Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension","volume":"16","author":"Horio","year":"2003","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.amjms.2025.11.009_bib0023","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1038\/s41598-021-82998-4","article-title":"The association between impairment of HDL cholesterol efflux capacity and atrial remodeling in atrial fibrillation","volume":"11","author":"Minami-Takano","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2025.11.009_bib0024","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.hrthm.2006.05.010","article-title":"Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction","volume":"3","author":"Hanna","year":"2006","journal-title":"Heart Rhythm"},{"issue":"9839","key":"10.1016\/j.amjms.2025.11.009_bib0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0140-6736(12)61241-0","article-title":"Subclinical thyroid disorders","volume":"380","author":"Mooijaart","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2025.11.009_bib0026","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1586\/erc.10.79","article-title":"Cholesterol and cardiac arrhythmias","volume":"8","author":"Goonasekara","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjms.2025.11.009_bib0027","doi-asserted-by":"crossref","DOI":"10.1038\/srep43764","article-title":"Cholesterol depletion impairs contractile machinery in neonatal rat cardiomyocytes","volume":"7","author":"Hissa","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.amjms.2025.11.009_bib0028","series-title":"The Effect of Inflammation and Infection on Lipids and Lipoproteins","author":"Feingold","year":"2022"},{"key":"10.1016\/j.amjms.2025.11.009_bib0029","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1038\/s41591-023-02610-2","article-title":"Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c","volume":"29","year":"2023","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0030","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jacl.2019.12.002","article-title":"Blood lipid profiles and risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies","volume":"14","author":"Guan","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"4","key":"10.1016\/j.amjms.2025.11.009_bib0031","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jc.2018-01656","article-title":"Association between triglyceride level and glycemic control among insulin-treated patients with type 2 diabetes","volume":"104","author":"Zheng","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"10.1016\/j.amjms.2025.11.009_bib0032","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1093\/eurjpc\/zwae285","article-title":"HbA1c variability and adverse outcomes in patients treated for atrial fibrillation: beyond glycaemic control?","volume":"31","author":"Salle","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0033","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12933-024-02194-2","article-title":"Effect of physical activity on incident atrial fibrillation in individuals with varying duration of diabetes: a nationwide population study","volume":"23","author":"Choi","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0034","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12933-024-02388-8","article-title":"The effect of non-insulin-based insulin resistance indices on the prediction of recurrence in patients with atrial fibrillation undergoing radiofrequency catheter ablation","volume":"23","author":"Luo","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"15","key":"10.1016\/j.amjms.2025.11.009_bib0035","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1093\/eurjpc\/zwae199","article-title":"Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI study","volume":"31","author":"Ray","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"10.1016\/j.amjms.2025.11.009_bib0036","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.amjms.2025.11.009_bib0037","doi-asserted-by":"crossref","first-page":"3634","DOI":"10.3390\/jcm9113634","article-title":"Recent updates and advances in the use of glycated albumin for the diagnosis and monitoring of diabetes and renal, cerebro- and cardio-metabolic diseases","volume":"9","author":"Giglio","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.amjms.2025.11.009_bib0038","first-page":"zwaf242","article-title":"GLP-1 analogues and prevention of atrial fibrillation: clinical and mechanistic insights","author":"Ren","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0039","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/ehf2.15049","article-title":"Real-world data on Empagliflozin and Dapagliflozin use in patients with HEART failure: the RED-HEART study","volume":"12","author":"Kocabas","year":"2025","journal-title":"ESC Heart Fail"},{"issue":"8","key":"10.1016\/j.amjms.2025.11.009_bib0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028496","article-title":"Association of chronic kidney disease with atrial fibrillation in the general adult population: a nationwide population-based study","volume":"12","author":"Kim","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.amjms.2025.11.009_bib0041","doi-asserted-by":"crossref","first-page":"285","DOI":"10.18231\/j.ijcbr.2021.061","article-title":"A study on evaluating blood urea and serum creatinine in diabetes mellitus patients","volume":"8","author":"Biri","year":"2022","journal-title":"Int J Clin Biochem Res"},{"issue":"4","key":"10.1016\/j.amjms.2025.11.009_bib0042","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Neprhrol"},{"issue":"9","key":"10.1016\/j.amjms.2025.11.009_bib0043","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2215\/CJN.04060318","article-title":"Incident atrial fibrillation and the risk of stroke in adults with chronic kidney disease: the Stockholm creatinine measurements (SCREAM) project","volume":"13","author":"Carrero","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0044","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12933-019-0983-1","article-title":"Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study","volume":"19","author":"Ahmadi","year":"2020","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.amjms.2025.11.009_bib0045","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1084\/jem.180.6.2027","article-title":"Promotion of mouse fibroblast collagen gene expression by mast cells stimulated via the Fc epsilon RI. Role for mast cell-derived transforming growth factor beta and tumor necrosis factor alpha","volume":"180","author":"Gordon","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.amjms.2025.11.009_bib0046","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1152\/ajplung.00163.2007","article-title":"TGF-beta-induced EMT: mechanisms and implications for fibrotic lung disease","volume":"293","author":"Willis","year":"2007","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0047","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002","article-title":"The role of TGF-\u03b2 signaling in myocardial infarction and cardiac remodeling","volume":"74","author":"Bujak","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.amjms.2025.11.009_bib0048","article-title":"Association of plasma transforming growth factor-\u03b21 levels and the risk of atrial fibrillation: a meta-analysis","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.amjms.2025.11.009_bib0049","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/clc.20713","article-title":"TGF-\u03b21 expression and atrial myocardium fibrosis increase in atrial fibrillation secondary to rheumatic heart disease","volume":"16;33","author":"Xiao","year":"2010","journal-title":"Clin Cardiol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2567.2006.02336.x","article-title":"Fibrosis in heart disease: understanding the role of transforming growth factor-\u03b21 in cardiomyopathy, valvular disease and arrhythmia","volume":"118","author":"Khan","year":"2006","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0051","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.hrthm.2012.08.043","article-title":"Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation","volume":"10","author":"Abed","year":"2013","journal-title":"Heart Rhythm"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0052","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/hrt.2003.022707","article-title":"Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor \u03b21 in obese Zucker rats by perindopril","volume":"91","author":"Toblli","year":"2005","journal-title":"Heart"},{"issue":"18","key":"10.1016\/j.amjms.2025.11.009_bib0053","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200005043421807","article-title":"Role of transforming growth factor-\u03b2 in human disease","volume":"342","author":"Blobe","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjms.2025.11.009_bib0054","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s00392-010-0248-1","article-title":"Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure","volume":"100","author":"Behnes","year":"2011","journal-title":"Clin Res Cardiol"},{"issue":"4","key":"10.1016\/j.amjms.2025.11.009_bib0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.hlc.2017.04.007","article-title":"Association of systemic inflammation score with atrial fibrillation: a case-control study with propensity score matching","volume":"27","author":"Zhang","year":"2018","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.amjms.2025.11.009_bib0056","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fphys.2019.00135","article-title":"The association between diabetes mellitus and atrial fibrillation: clinical and mechanistic insights","volume":"10","author":"Bohne","year":"2019","journal-title":"Front Physiol"},{"key":"10.1016\/j.amjms.2025.11.009_bib0057","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ijcard.2018.10.020","article-title":"Role of inflammatory signaling in atrial fibrillation","volume":"287","author":"Scott","year":"2019","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.amjms.2025.11.009_bib0058","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.numecd.2022.03.008","article-title":"C-reactive protein and atrial fibrillation: insights from epidemiological and mendelian randomization studies","volume":"32","author":"Li","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/j.amjms.2025.11.009_bib0059","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.3390\/jcm9092807","article-title":"Early biomarkers of neurodegenerative and neurovascular disorders in diabetes","volume":"9","author":"Gasecka","year":"2020","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.amjms.2025.11.009_bib0060","first-page":"305","article-title":"Clinical importance of high-sensitivity troponin T in patients without coronary artery disease","volume":"7","author":"Askin","year":"2019","journal-title":"North Clin Istanb"},{"key":"10.1016\/j.amjms.2025.11.009_bib0061","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.amjcard.2013.04.060","article-title":"Usefulness of high-sensitivity cardiac troponin T and brain natriuretic peptide as biomarkers of myocardial fibrosis in patients with hypertrophic cardiomyopathy","volume":"112","author":"Kawasaki","year":"2013","journal-title":"Am J Cardiol"},{"issue":"16","key":"10.1016\/j.amjms.2025.11.009_bib0062","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1161\/CIRCULATIONAHA.105.609974","article-title":"Prevalence and determinants of troponin T elevation in the general population","volume":"113","author":"Wallace","year":"2006","journal-title":"Circ"},{"key":"10.1016\/j.amjms.2025.11.009_bib0063","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc11-s209","article-title":"Heart in diabetes: a microvascular disease","volume":"34","author":"Laakso","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.amjms.2025.11.009_bib0064","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/08037051.2011.618262","article-title":"Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: a tissue Doppler study in echocardiographic practice","volume":"21","author":"Cuspidi","year":"2012","journal-title":"Blood Press"},{"issue":"5","key":"10.1016\/j.amjms.2025.11.009_bib0065","first-page":"473","article-title":"Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets results from a large international multicenter study","volume":"4","author":"Rusinaru","year":"2011","journal-title":"Circ"},{"issue":"5","key":"10.1016\/j.amjms.2025.11.009_bib0066","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4065\/76.5.467","article-title":"Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women","volume":"76","author":"Tsang","year":"2001","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.amjms.2025.11.009_bib0067","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1186\/s12872-023-03403-8","article-title":"Association between systemic inflammatory response index and left ventricular remodeling and systolic dysfunction in atrial fibrillation patients","volume":"23","author":"Chi","year":"2023","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0068","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12933-024-02420-x","article-title":"Metabolically \u201cextremely unhealthy\u201d obese and non-obese people with diabetes and the risk of cardiovascular adverse events: the Silesia diabetes - heart project","volume":"23","author":"Janota","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.amjms.2025.11.009_bib0069","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12933-024-02176-4","article-title":"The worsening effect of paroxysmal atrial fibrillation on left ventricular function and deformation in type 2 diabetes mellitus patients: a 3.0 T cardiovascular magnetic resonance feature tracking study","volume":"23","author":"Li","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"10.1016\/j.amjms.2025.11.009_bib0070","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"January","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.amjms.2025.11.009_bib0071","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.amjms.2025.11.009_bib0072","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/1755-5922.12089","article-title":"Diabetes mellitus and atrial remodeling: mechanisms and potential upstream therapies","volume":"32","author":"Zhang","year":"2014","journal-title":"Cardiovasc Ther"},{"issue":"21","key":"10.1016\/j.amjms.2025.11.009_bib0073","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.3390\/jcm10214863","article-title":"The effect of diabetes mellitus on the recurrence of atrial fibrillation after ablation","volume":"10","author":"Guckel","year":"2021","journal-title":"J Clin Med"},{"issue":"16","key":"10.1016\/j.amjms.2025.11.009_bib0074","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.3390\/nu16162672","article-title":"Exploring diet-based treatments for atrial fibrillation: patient empowerment and citizen science as a model for quality-of-life-centered solutions","volume":"16","author":"Kuipers","year":"2024","journal-title":"Nutrients"},{"issue":"21","key":"10.1016\/j.amjms.2025.11.009_bib0075","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.jacc.2014.09.028","article-title":"Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study","volume":"64","author":"Pathak","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.amjms.2025.11.009_bib0076","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/cimb47070559","article-title":"Atrial fibrillation in diabetes: pathogenesis and targeted rhythm control strategies","volume":"47","author":"Grigoriou","year":"2025","journal-title":"Curr Issues Mol Biol"},{"issue":"17","key":"10.1016\/j.amjms.2025.11.009_bib0077","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022222","article-title":"Sodium-glucose co-transporter inhibitors and atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials","volume":"10","author":"Pandey","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"10.1016\/j.amjms.2025.11.009_bib0078","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.3390\/biomedicines13071557","article-title":"Identifying high-risk atrial fibrillation in diabetes: evidence from nomogram and plasma metabolomics analysis","volume":"13","author":"Luo","year":"2025","journal-title":"Biomedicines"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962925012765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:37:34Z","timestamp":1773851854000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962925012765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0002962925012765"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2025.11.009","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interrelationships between diabetes and atrial fibrillation: Comparative assessment of clinical markers and possible therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2025.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}